KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Share-based Compensation (2016 - 2025)

Merck (MRK) has disclosed Share-based Compensation for 17 consecutive years, with $205.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 9.63% to $205.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $820.0 million, a 7.75% increase, with the full-year FY2025 number at $820.0 million, up 7.75% from a year prior.
  • Share-based Compensation was $205.0 million for Q4 2025 at Merck, roughly flat from $204.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $216.0 million in Q2 2025 to a low of $111.0 million in Q1 2021.
  • A 5-year average of $162.3 million and a median of $165.5 million in 2023 define the central range for Share-based Compensation.
  • Biggest YoY gain for Share-based Compensation was 25.71% in 2021; the steepest drop was 0.86% in 2021.
  • Merck's Share-based Compensation stood at $119.0 million in 2021, then grew by 21.85% to $145.0 million in 2022, then increased by 15.17% to $167.0 million in 2023, then rose by 11.98% to $187.0 million in 2024, then increased by 9.63% to $205.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Share-based Compensation are $205.0 million (Q4 2025), $204.0 million (Q3 2025), and $216.0 million (Q2 2025).